A case of hair changes during semaglutide use

This article discusses the source author’s earlier literature, cases and experiences. Research populations and limitations matter; individual diagnosis and treatment require clinical assessment.

This article records an individual clinical observation by Dr. Hyemi Yu. The original’s legal-compliance statement is not a finding of approval for this republication.

The source follows one person using semaglutide from December while managing weight and glucose. It reports an 11kg reduction, cholesterol and uric-acid changes and use of a continuous glucose monitor.

Alopecia areata changing in photographs does not prove a semaglutide treatment effect. Natural course, other treatments, stress and nutrition may contribute. Telogen effluvium after rapid weight loss, alopecia areata and other causes need to be distinguished.

This article does not offer semaglutide as hair-loss treatment. Hair changes or gastrointestinal and other adverse effects during use should be discussed with the prescribing clinician; it is not a self-directed start or withdrawal plan.

The source includes a slide from a clinician lecture. It emphasizes that obesity deserves care rather than blame for weak will. A lecture slide is not evidence that the drug treats alopecia.